Log In
Print
BCIQ
Print
Print this Print this
 

GL-2045

  Manage Alerts
Collapse Summary General Information
Company Gliknik Inc.
DescriptionRecombinant stradomer -- laboratory-made clusters of the Fc portion of human antibodies -- designed to mimic IV immunoglobulin (IVIG)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today